There was some earlier conjecture on the size of the market and potential annual future sales for ReCell re: interview with Bill Dolphin. Re-listening to the interview, Dolphin discusses the different market segments which ReCell is targeting - chronic wounds, burns and cosmetic applications e.g. wrinkles, acne scarring.
"We can see that, on the order of 10-12 million procedures will be done per year utilising ReCell," said Dolphin.
The number of ReCell kits which Dolphin can visualize being sold is 10-12 million annually. Assuming a sales value per kit of $750, Dolphin is projecting a future turnover of $7.5B. Of course the future could be 5-15 years away. The sheer scale of the market and the revolutionary impact of the ReCell procedure will - at some point in time - make Avita Medical a hotly contested takeover target. Of course, as Dolphin appears to suggest in the interview - that's the whole point.
- Forums
- ASX - By Stock
- onemedplace video
There was some earlier conjecture on the size of the market and...
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.63 |
Change
0.030(1.15%) |
Mkt cap ! $185.2M |
Open | High | Low | Value | Volume |
$2.60 | $2.65 | $2.60 | $317.8K | 121.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5725 | $2.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.64 | 76 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5725 | 2.620 |
2 | 5900 | 2.600 |
1 | 2540 | 2.550 |
1 | 1000 | 2.540 |
2 | 9190 | 2.520 |
Price($) | Vol. | No. |
---|---|---|
2.640 | 76 | 1 |
2.650 | 761 | 2 |
2.660 | 4000 | 1 |
2.670 | 10160 | 2 |
2.680 | 100 | 1 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |